| ISIN | CH0492935355 |
|---|---|
| Valor Number | 49293535 |
| Bloomberg Global ID | CHSRIA SW |
| Fund Name | UBS ETF (CH) - UBS MSCI Switzerland IMI Socially Responsible ETF CHF acc |
| Fund Provider |
UBS Fund Management (Switzerland) AG
Basel, Switzerland Phone: +41 61 288 75 01 E-Mail: sh-ubs-funds-feedback@ubs.com Web: www.ubs.com/fonds |
| Fund Provider | UBS Fund Management (Switzerland) AG |
| Representative in Switzerland | |
| Distributor(s) |
UBS Fund Management (Switzerland) AG Basel Phone: +41 61 288 49 10 |
| Asset Class | Asset Allocation |
| EFC Category | Equity Switzerland |
| Distribution Policy | Accumulation |
| Home Country | Switzerland |
| Issuing Condition | The fund charges a transaction fee (contribution towards expenses incurred in the investment of new assets) |
| Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
| Investment Strategy *** | n/a |
| Peculiarities |
| Current Price * | 21.34 CHF | 27.11.2025 |
|---|---|---|
| Previous Price * | 21.29 CHF | 26.11.2025 |
| 52 Week High * | 21.56 CHF | 12.11.2025 |
| 52 Week Low * | 17.97 CHF | 09.04.2025 |
| NAV * | 21.34 CHF | 27.11.2025 |
| Issue Price * | 21.34 CHF | 27.11.2025 |
| Redemption Price * | 21.34 CHF | 27.11.2025 |
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 524,227,216 | |
| Unit/Share Assets *** | 260,956,528 | |
| Trading Information SIX | ||
| YTD Performance | +9.29% |
31.12.2024 - 27.11.2025
31.12.2024 27.11.2025 |
|---|---|---|
| 1 month | +0.61% |
27.10.2025 - 27.11.2025
27.10.2025 27.11.2025 |
| 3 months | +1.39% |
27.08.2025 - 27.11.2025
27.08.2025 27.11.2025 |
| 6 months | +1.03% |
27.05.2025 - 27.11.2025
27.05.2025 27.11.2025 |
| 1 year | +8.55% |
27.11.2024 - 27.11.2025
27.11.2024 27.11.2025 |
| 2 years | +23.74% |
27.11.2023 - 27.11.2025
27.11.2023 27.11.2025 |
| 3 years | +26.95% |
28.11.2022 - 27.11.2025
28.11.2022 27.11.2025 |
| 5 years | +33.80% |
27.11.2020 - 27.11.2025
27.11.2020 27.11.2025 |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Roche Holding AG | 11.01% | |
|---|---|---|
| Novartis AG Registered Shares | 10.18% | |
| Zurich Insurance Group AG | 10.04% | |
| Nestle SA | 9.98% | |
| Lonza Group Ltd | 9.90% | |
| ABB Ltd | 9.90% | |
| Alcon Inc | 9.80% | |
| UBS Group AG Registered Shares | 9.75% | |
| Givaudan SA | 9.50% | |
| Swiss Re AG | 9.32% | |
| Last data update | 25.11.2025 | |
| TER | 0.28% |
|---|---|
| TER date | 30.06.2024 |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 0.60% |
| Ongoing Charges *** | 0.28% |
|
SRRI ***
|
|
| SRRI date *** | 31.10.2025 |